Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$0.23

-0.01 (-2.92%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +16,779.8% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $0.23

Current
$0.23

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

9,543.8%

Low target

Base Case

$39.33

+16,779.8%

Avg target

Bull Case

$48.65

+20,779.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$3.09

-92.5% from high

52-Week Low

$0.23

+0.8% from low

Target vs 52W High

$39.33

+1,172.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+2.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.5%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.6%